Cite
Half-time bone scintigraphy in prostate and breast cancer patients.
MLA
Grootjans, Willem, et al. “Half-Time Bone Scintigraphy in Prostate and Breast Cancer Patients.” The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society Of., vol. 62, no. 3, Sept. 2018, pp. 303–12. EBSCOhost, https://doi.org/10.23736/S1824-4785.16.02830-2.
APA
Grootjans, W., Serém, S. J., Gomes, M. I., Heijmen, L., Bulten, B. F., Mijnheere, E. P., Hermsen, R., & van den Broek, W. J. (2018). Half-time bone scintigraphy in prostate and breast cancer patients. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society Of., 62(3), 303–312. https://doi.org/10.23736/S1824-4785.16.02830-2
Chicago
Grootjans, Willem, Sara J Serém, Monique I Gomes, Linda Heijmen, Ben F Bulten, Eddy P Mijnheere, Rick Hermsen, and Wim J van den Broek. 2018. “Half-Time Bone Scintigraphy in Prostate and Breast Cancer Patients.” The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society Of. 62 (3): 303–12. doi:10.23736/S1824-4785.16.02830-2.